Can N-acetylcysteine reduce red blood cell transfusion burden in patients with transfusion-dependent β-thalassemia?

References

• Cappellini M-D, Cohen A, Eleftheriou A, Piga A, Porter J, Taher A. Guidelines for the clinical management of thalassaemia. 2013.
   Google Scholar
• Borgna-Pignatti C, Galanello R. Thalassemias and related disorders: Quantitative disorders of hemoglobin synthesis. Wintrobe’s Clin Hematol. 2004;42:1319–1365.
   Google Scholar
• Brittenham GM, Cohen AR, McLaren CE, et al. Hepatic iron stores and plasma ferritin concentration in patients with sickle cell anemia and thalassemia major. Am J Hematol. 1993;42(1):81–85. doi:10.1002/ajh.2830420116.
   PubMed Web of Science ®Google Scholar
• Hershko C. Pathogenesis and management of iron toxicity in thalassemia. Ann N Y Acad Sci. 2010;1202(1):1–9. doi:10.1111/j.1749-6632.2010.05544.x.
   PubMedGoogle Scholar
• Hubel CA, Kagan VE, Kisin ER, McLaughlin MK, Roberts JM. Increased ascorbate radical formation and ascorbate depletion in plasma from women with preeclampsia: Implications for oxidative stress. Free Radic Biol Med. 1997;23(4):597–609. doi:10.1016/s0891-5849(97)00010-5.
   PubMed Web of Science ®Google Scholar
• Livrea M, Tesoriere L, Pintaudi A, et al. Oxidative stress and antioxidant status in beta-thalassemia major: Iron overload and depletion of lipid-soluble antioxidants. 1996.
   Google Scholar
• Amer J, Atlas D, Fibach E. N-acetylcysteine amide (AD4) attenuates oxidative stress in beta-thalassemia blood cells. Biochim Biophys Acta. 2008;1780(2):249–255. doi:10.1016/j.bbagen.2007.11.009.
   PubMed Web of Science ®Google Scholar
• Pavlova L, Savov V, Petkov H, Charova I. Oxidative stress in patients with beta-thalassemia major. Prilozi. 2007;28(1):145–154.
   PubMedGoogle Scholar
• Ghone RA, Kumbar K, Suryakar A, Katkam R, Joshi N. Oxidative stress and disturbance in antioxidant balance in beta thalassemia major. Indian J Clin Biochem. 2008;23(4):337–340. doi:10.1007/s12291-008-0074-7.
   PubMedGoogle Scholar
• Chakraborty D, Bhattacharyya M. Antioxidant defense status of red blood cells of patients with β-thalassemia and Eβ-thalassemia. Clin Chim Acta. 2001;305(1–2):123–129. doi:10.1016/s0009-8981(00)00428-9.
   PubMed Web of Science ®Google Scholar
• Cheng M, Ho H, Tseng H, Lee CH, Shih L, Chiu D. Antioxidant deficit and enhanced susceptibility to oxidative damage in individuals with different forms of α-thalassaemia. Br J Haematol. 2005;128(1):119–127. doi:10.1111/j.1365-2141.2004.05257.x.
   PubMed Web of Science ®Google Scholar
• Faintuch J, Aguilar PB, Nadalin W. Relevance of N-acetylcysteine in clinical practice: Fact, myth or consequence?-does added glutamine change the effect? Nutrition. 1999;15(2):177–179.):doi:10.1016/s0899-9007(98)00060-4.
   PubMed Web of Science ®Google Scholar
• Demedts M, Behr J, Buhl R, et al. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med. 2005;353(21):2229–2242. doi:10.1056/NEJMoa042976.
   PubMed Web of Science ®Google Scholar
• Grandjean EM, Berthet P, Ruffmann R, Leuenberger P. Efficacy of oral long-term Nacetylcysteine in chronic bronchopulmonary disease: A meta-analysis of published double-blind, placebo-controlled clinical trials. Clin Ther. 2000;22(2):209–221. doi:10.1016/S0149-2918(00)88479-9.
   PubMed Web of Science ®Google Scholar
• Rachmilewitz EA, Weizer-Stern O, Adamsky K, et al. Role of iron in inducing oxidative stress in thalassemia: Can it be prevented by inhibition of absorption and by antioxidants? Ann N Y Acad Sci. 2005;1054(1):118–123. doi:10.1196/annals.1345.014.
   PubMedGoogle Scholar
• Haghpanah S, Hosseini-Bensenjan M, Zekavat O, et al. The effect of Vitamin E and N-acetyl cysteine on oxidative status and hemoglobin level in transfusion-dependent thalassemia patients: A systematic review and meta-analysis. Iran J Blood Cancer. 2023;15(1):22–35. doi:10.58209/ijbc.15.1.22.
   Google Scholar
• Eren F, Koca Yozgat A, Firat Oğuz E, et al. A new perspective for potential organ damage due to iron-mediated oxidation in thalassemia major patients. J Clin Med. 2023;12(6):2422. doi:10.3390/jcm12062422.
   PubMed Web of Science ®Google Scholar
• Ozdemir ZC, Koc A, Aycicek A, Kocyigit A. N-acetylcysteine supplementation reduces oxidative stress and DNA damage in children with β-thalassemia. Hemoglobin. 2014;38(5):359–364. doi:10.3109/03630269.2014.951890.
   PubMed Web of Science ®Google Scholar
• Haghpanah S, Cohan N, Bordbar M, et al. Effects of three months of treatment with vitamin E and N-acetyl cysteine on the oxidative balance in patients with transfusion-dependent β-thalassemia. Ann Hematol. 2021;100(3):635–644. doi:10.1007/s00277-020-04346-2.
   PubMed Web of Science ®Google Scholar
• Khail A, Meabed MH, Mohamed YA, Abd-Elkareem RM. Effect of N-acetylcysteine on total oxidant status in children with β-thalassemia major. Med Updates. 2020;3(3):84–96. doi:10.21608/muj.2020.41090.1023.
   Google Scholar
• Karimi M, Amirmoezi F, Haghpanah S, et al. Correlation of serum ferritin levels with hepatic MRI T2 and liver iron concentration in nontransfusionbetathalassemia intermediate patients: A contemporary issue. PediatrHematol Oncol. 2017;34(5):292–297.
   Google Scholar
• Pattanakuhar S, Phrommintikul A, Tantiworawit A, Srichairattanakool S, Chattipakorn SC, Chattipakorn N. N-acetylcysteine restored heart rate variability and prevented serious adverse events in transfusion-dependent thalassemia patients: A double-blind single center randomized controlled trial. Int J Med Sci. 2020;17(9):1147–1155. doi:10.7150/ijms.45795.
   PubMed Web of Science ®Google Scholar
• Yanpanitch O-u, Hatairaktham S, Charoensakdi R, et al. Treatment of β-thalassemia/hemoglobin E with antioxidant cocktails results in decreased oxidative stress, increased hemoglobin concentration, and improvement of the hypercoagulable state. Oxid Med Cell Longev. 2015;2015:537954–537958. doi:10.1155/2015/537954.
   PubMed Web of Science ®Google Scholar